Genomics & Informatics

  • 제14권3호
  • /
  • Pages.104-111
  • /
  • 2016
  • /
  • 1598-866X(pISSN)
  • /
  • 2234-0742(eISSN)
한국유전체학회 (Korea Genome Organization)
권호 표지
DOI QR코드

DOI QR Code

Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus

  • Sahoo, Maheswata (Bioinformatics Centre & Biochemistry, Mahatma Gandhi Institute of Medical Sciences) ;
  • Jena, Lingaraja (Bioinformatics Centre & Biochemistry, Mahatma Gandhi Institute of Medical Sciences) ;
  • Daf, Sangeeta (Obstetrics & Gynaecology, Datta Meghe Institute of Medical Sciences (Deemed University)) ;
  • Kumar, Satish (Bioinformatics Centre & Biochemistry, Mahatma Gandhi Institute of Medical Sciences)
  • 투고 : 2016.05.23
  • 심사 : 2016.06.29
  • 발행 : 2016.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Zika virus (ZIKV) is a mosquito borne pathogen, belongs to Flaviviridae family having a positive-sense single-stranded RNA genome, currently known for causing large epidemics in Brazil. Its infection can cause microcephaly, a serious birth defect during pregnancy. The recent outbreak of ZIKV in February 2016 in Brazil realized it as a major health risk, demands an enhanced surveillance and a need to develop novel drugs against ZIKV. Amodiaquine, prochlorperazine, quinacrine, and berberine are few promising drugs approved by Food and Drug Administration against dengue virus which also belong to Flaviviridae family. In this study, we performed molecular docking analysis of these drugs against nonstructural 3 (NS3) protein of ZIKV. The protease activity of NS3 is necessary for viral replication and its prohibition could be considered as a strategy for treatment of ZIKV infection. Amongst these four drugs, berberine has shown highest binding affinity of -5.8 kcal/mol and it is binding around the active site region of the receptor. Based on the properties of berberine, more similar compounds were retrieved from ZINC database and a structure-based virtual screening was carried out by AutoDock Vina in PyRx 0.8. Best 10 novel drug-like compounds were identified and amongst them ZINC53047591 (2-(benzylsulfanyl)-3-cyclohexyl-3H-spiro[benzo[h]quinazoline-5,1'-cyclopentan]-4(6H)-one) was found to interact with NS3 protein with binding energy of -7.1 kcal/mol and formed H-bonds with Ser135 and Asn152 amino acid residues. Observations made in this study may extend an assuring platform for developing anti-viral competitive inhibitors against ZIKV infection.

키워드

참고문헌

  1. Thiel JH, Collet MS, Gould EA, Heinz FX, Meyers G, Fauquet CM, et al. Family Flaviviridae. In: Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses (Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, eds.). San Diego: Elsevier Academic Press, 2005. pp. 981-998.
  2. Hayes EB. Zika virus outside Africa. Emerg Infect Dis 2009;15:1347-1350. https://doi.org/10.3201/eid1509.090442
  3. Foy BD, Kobylinski KC, Chilson Foy JL, Blitvich BJ, Travassos da Rosa A, Haddow AD, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 2011;17:880-882. https://doi.org/10.3201/eid1705.101939
  4. Schuler-Faccini L, Ribeiro EM, Feitosa IM, Horovitz DD, Cavalcanti DP, Pessoa A, et al. Possible association between Zika virus infection and microcephaly-Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016;65:59-62. https://doi.org/10.15585/mmwr.mm6503e2
  5. Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009;360:2536-2543. https://doi.org/10.1056/NEJMoa0805715
  6. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008;14:1232-1239. https://doi.org/10.3201/eid1408.080287
  7. Haddow AJ, Williams MC, Woodall JP, Simpson DI, Goma LK. Twelve isolations of Zika virus from Aedes (Stegomyia) africanus (Theobald) taken in and above a Uganda forest. Bull World Health Organ 1964;31:57-69.
  8. Pan American Health Organization; World Health Organization; Regional Office for the Americas. Zika virus infection. Washington, DC: Pan American Health Organization, 2015. Accessed 2015 May 7. Available from: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=30075=en.
  9. Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, et al. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res 2010;87:125-148. https://doi.org/10.1016/j.antiviral.2009.11.009
  10. Baronti C, Piorkowski G, Charrel RN, Boubis L, Leparc-Goffart I, de Lamballerie X. Complete coding sequence of Zika virus from a French Polynesia outbreak in 2013. Genome Announc 2014;2:e00500-e00514.
  11. Furuichi Y, Shatkin AJ. Viral and cellular mRNA capping: past and prospects. Adv Virus Res 2000;55:135-184.
  12. Egloff MP, Benarroch D, Selisko B, Romette JL, Canard B. An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J 2002;21:2757-2768. https://doi.org/10.1093/emboj/21.11.2757
  13. Ray D, Shah A, Tilgner M, Guo Y, Zhao Y, Dong H, et al. West Nile virus 5'-cap structure is formed by sequential guanine N-7 and ribose 2'-O methylations by nonstructural protein 5. J Virol 2006;80:8362-8370. https://doi.org/10.1128/JVI.00814-06
  14. Speight G, Coia G, Parker MD, Westaway EG. Gene mapping and positive identification of the non-structural proteins NS2A, NS2B, NS3, NS4B and NS5 of the Flavivirus Kunjin and their cleavage sites. J Gen Virol 1988;69(Pt1):23-34. https://doi.org/10.1099/0022-1317-69-1-23
  15. Nowak T, Farber PM, Wengler G, Wengler G. Analyses of the terminal sequences of West Nile virus structural proteins and of the in vitro translation of these proteins allow the proposal of a complete scheme of the proteolytic cleavages involved in their synthesis. Virology 1989;169:365-376. https://doi.org/10.1016/0042-6822(89)90162-1
  16. Falgout B, Markoff L. Evidence that Flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum. J Virol 1995;69:7232-7243.
  17. Leung D, Schroder K, White H, Fang NX, Stoermer MJ, Abbenante G, et al. Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J Biol Chem 2001;276:45762-45771. https://doi.org/10.1074/jbc.M107360200
  18. Bera AK, Kuhn RJ, Smith JL. Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease. J Biol Chem 2007;282:12883-12892. https://doi.org/10.1074/jbc.M611318200
  19. Services Yap State Department of Health. Zika Virus: Information for Clinicians and Other Health Professionals. Yap: Yap State Department of Health, 2007.
  20. Boonyasuppayakorn S, Reichert ED, Manzano M, Nagarajan K, Padmanabhan R. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity. Antiviral Res 2014;106:125-134. https://doi.org/10.1016/j.antiviral.2014.03.014
  21. Simanjuntak Y, Liang JJ, Lee YL, Lin YL. Repurposing of prochlorperazine for use against dengue virus infection. J Infect Dis 2015;211:394-404. https://doi.org/10.1093/infdis/jiu377
  22. Shum D, Smith JL, Hirsch AJ, Bhinder B, Radu C, Stein DA, et al. High-content assay to identify inhibitors of dengue virus infection. Assay Drug Dev Technol 2010;8:553-570. https://doi.org/10.1089/adt.2010.0321
  23. Ekins S, Freundlich JS, Clark AM, Anantpadma M, Davey RA, Madrid P. Machine learning models identify molecules active against the Ebola virus in vitro. F1000Res 2015;4:1091.
  24. Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol 2015;1263:243-250.
  25. Kelley LA, Sternberg MJ. Protein structure prediction on the web: a case study using the Phyre server. Nat Protoc 2009;4:363-371. https://doi.org/10.1038/nprot.2009.2
  26. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455-461.
  27. National Center for Biotechnology Information. Bethesda: U.S. National Library of Medicine, 2016. Accessed 2016 Jan 15. Available from: http://www.ncbi.nlm.nih.gov.
  28. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993;26:283-291. https://doi.org/10.1107/S0021889892009944
  29. Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007;35:W407-W410. https://doi.org/10.1093/nar/gkm290
  30. Wallner B, Elofsson A. Can correct protein models be identified? Protein Sci 2003;12:1073-1086. https://doi.org/10.1110/ps.0236803
  31. Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 1993;2:1511-1519. https://doi.org/10.1002/pro.5560020916
  32. Wang Y, Bolton E, Dracheva S, Karapetyan K, Shoemaker BA, Suzek TO, et al. An overview of the PubChem BioAssay resource. Nucleic Acids Res 2010;38:D255-D266. https://doi.org/10.1093/nar/gkp965
  33. de Castro E, Sigrist CJ, Gattiker A, Bulliard V, Langendijk-Genevaux PS, Gasteiger E, et al. ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res 2006;34:W362-W365. https://doi.org/10.1093/nar/gkl124
  34. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403-410. https://doi.org/10.1016/S0022-2836(05)80360-2
  35. Miller RH, Purcell RH. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A 1990;87:2057-2061. https://doi.org/10.1073/pnas.87.6.2057

피인용 문헌

  1. Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives vol.8, pp.1664-302X, 2017, https://doi.org/10.3389/fmicb.2017.01469
  2. The Race To Find Antivirals for Zika Virus vol.61, pp.6, 2017, https://doi.org/10.1128/AAC.00411-17
  3. Computational drug discovery for the Zika virus vol.54, pp.spe, 2018, https://doi.org/10.1590/s2175-97902018000001002
  4. In silico approaches to Zika virus drug discovery vol.13, pp.9, 2018, https://doi.org/10.1080/17460441.2018.1515909
  5. Zika virus, vaccines, and antiviral strategies vol.16, pp.6, 2018, https://doi.org/10.1080/14787210.2018.1483239